Covidien to sell its Confluent Surgical product line
Posted in the Bandera Forum
Since: Sep 13
#1 Oct 28, 2013
Covidien plc (NYSE:COV) reported that it has entered into a definitive agreement with Integra LifeSciences Holdings Corp.(Nasdaq:IART) to sell its Confluent Surgical product line.
Under the terms of the agreement, COV will receive an initial cash payment of $235 million from IART upon the closing of the transaction. Additionally, COV may receive up to $30 million, contingent upon the achievement of certain performance measures related to the transition of the Confluent Surgical business to IART.
Full article at http://mikezaman.com/27128/stocks/covidien-ny...
Add your comments below
|Secrets in the Somky Mountains on Dateline||3 hr||Insider||1|
|Cleaning Up Ham Radio in San Antonio (Aug '10)||4 hr||Oh Poor Baby||7,070|
|whoa!!!!||5 hr||Cristal Slapped A...||10|
|cant sleep||5 hr||Little Johntny Da...||9|
|Is it illegal||7 hr||Honky||2|
|Does Little Johnny's cheek hurt...||14 hr||Donald Trump||15|
|Doug Supernaw: Yet More Sad News for Troubled F... (May '11)||Oct 21||Dane Baker||42|
Find what you want!
Search Bandera Forum Now
Copyright © 2016 Topix LLC